Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Office Supply Vendor Faces Proposed Class Action Over Counterfeit N95 Masks

Executive Summary

The proposed class action suit alleges that W.B. Mason took advantage of the pandemic by overcharging for the phony respirators.

You may also be interested in...



CDC Awards Counterfeit Mask Prevention Contract To Underwriter Laboratories

The safety certification company will work with the US government to help prevent the sale of counterfeit respirators.

3M Files 5 Lawsuits Over Fraudulent N95 Mask Vendors

3M is seeking injunctions against several entities that they say made fraudulent offers to supply 3M N95 respirators to government agencies at inflated price points.

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT143557

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel